| 000 | 01784 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514014829.0 | ||
| 264 | 0 | _c20020131 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.M108658200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCardozo, A K | |
| 245 | 0 | 0 |
_aA comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cDec 2001 |
||
| 300 |
_a48879-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytokines _xpharmacology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _ximmunology |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aI-kappa B Proteins _xgenetics |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xgenetics |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aHeimberg, H | |
| 700 | 1 | _aHeremans, Y | |
| 700 | 1 | _aLeeman, R | |
| 700 | 1 | _aKutlu, B | |
| 700 | 1 | _aKruhøffer, M | |
| 700 | 1 | _aØrntoft, T | |
| 700 | 1 | _aEizirik, D L | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 276 _gno. 52 _gp. 48879-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M108658200 _zAvailable from publisher's website |
| 999 |
_c11604291 _d11604291 |
||